The Coronavirus (COVID-19) crisis has supported the category’s performance in Spain. The pandemic arrived and started to mushroom in February-March 2020, resulting in a steep increase in sales of analgesics in the country. The panic over a shortage of supply of analgesics, along with the high number of COVID-19 cases and fear of contamination, led to stockpiling in the first weeks of the crisis. However, chemists/pharmacies have remained open, which has helped to assuage such fears and level out...

Also Read: http://www.marketwatch.com/story/global-kid-makeup-kit-market-outlo...

Euromonitor International's Analgesics in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Also Read: http://www.marketwatch.com/story/global-studio-headphones-market-st...

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Analgesics market;

* Pinpoint growth sectors and identify factors driving change;

* Understand the competitive environment, the market’s major players and leading brands;

* Use five-year forecasts to assess how the market is predicted to develop.

Also Read: http://www.marketwatch.com/story/global-digital-cinema-projectors-m...

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

List OF CONTENTS AND TABLES

KEY DATA FINDINGS

2020 IMPACT

Perceived immunity/protection from Coronavirus (COVID-19) symptoms boosts sales of analgesics

Acceleration of healthier lifestyles trend as lockdown eases boosts topical analgesics/anaesthetic

Limited movement in company/brand shares or rankings as consumers seek familiarity at a time of crisis

RECOVERY AND OPPORTUNITIES

Lingering COVID-19 pandemic and fitness and demographic trends set to influence category performance in the forecast period

Also Read: http://www.marketwatch.com/story/global-digital-coupon-product-mark...

De-listing medicines like 1g paracetamol and 650g ibuprofen may stimulate OTC sales

Competition from cheaper reimbursed generics set to limit OTC sales growth

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2015-2020

Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020

Table 3 NBO Company Shares of Analgesics: % Value 2016-2020

Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020

Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025

Also Read: http://www.marketwatch.com/story/diabetic-foot-ulcer-therapy-produc...

Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

…continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105